Astellas Pharma has announced the availability of Xtandi (enzalutamide), a new treatment for advanced prostate cancer in patients who have failed on first-line hormonal treatments and docetaxel chemotherapy, in the UK. Administered ...
Tags: Astellas, Cancer Medication
Genentech, a member of the Roche Group, has obtained FDA priority review status for Obinutuzumab (GA101) to treat previously untreated chronic lymphocytic leukemia (CLL). The FDA has also accepted the company's biologics license ...
Tags: Genentech, FDA Priority
Scientists at the Institute of Cancer Research, London, The Royal Marsden NHS Foundation Trust and Queen Mary University of London have developed a new breast cancer test, dubbed as PAM50, to help women avoid unnecessary chemotherapy. The ...
Tags: Breast Cancer, Chemotherapy
The Japanese Ministry of Health, Labour and Welfare (MHLW) has cleared Roche's Avastin (bevacizumab) as a combination therapy and monotherapy to treat the aggressive form of brain cancer glioblastoma. The first new medicine that is ...
Tags: Glioblastoma Therapy, Medicine
Saladax Biomedical, US-based developer of diagnostic tests that optimize a patient's exposure to chemotherapy, has been certified as a registered CLIA Laboratory from the Office of Clinical Standards and Quality (OCSQ), a division of The ...
Tags: Laboratory Certification, Saladax
Stemline Therapeutics' SL-401 has won orphan drug designation from the Food and Drug Administration (FDA) for the treatment of aggressive hematologic malignancy blastic plasmacytoid dendritic cell neoplasm (BPDCN). With an orphan drug ...
Tags: Stemline Therapeutic, Orphan Drug
When looking to purchase a wig, consider its use and function in your life. The best quality wigs are made from human hair and require similar care, styling and attention to your own hair. When treated properly on a continued basis, they ...
Tags: Human Hair Wigs, wig, Arts
Danish biotechnology company Zealand Pharma and partner, the Swiss pharma group Helsinn have jointly cHelsinn's Phase IIa study with elsiglutide for the prevention of chemotherapy-induced diarrhea in cancer patients has been completed with ...
Tags: Health, Medicine, biotechnology
Astellas Pharma and Medivation have announced the submission of application for marketing approval of enzalutamide in Japan for the treatment of prostate cancer. The application was filed by Astellas with the Ministry of Health, Labour ...
Tags: Astellas, Marketing Application
Alethia Biotherapeutics has gained US patent for methods of treating carcinomas with antibodies targeting the region of secreted clusterin (sCLU) responsible for promoting epithelial-to-mesenchymal transition (EMT). The company along with ...
Tags: Alethia, US Patent, Cancer Treatment Methods
Posted by Jack Mans, Plant Operations Editor -- Packaging Digest, 5/11/2013 12:32:28 PM Although it won't be obvious to patients, a family of giant robots behind the scenes now counts and processes their medications. With a new automated ...
Tags: UCSF Robotic Pharmacy, Packaging
In the spirit of increasing awareness of the benefits of modern cloth diapers, Cutie Poops and Bottoms of Orland Park is helping children fighting cancer. The store recently participated in a worldwide event called The Great Cloth Diaper ...
Tags: Toys
Students at four District #210 Lincoln-Way high schools are participating in a program designed to make their local community a better environment in which to live, work and learn. T.E.A.M. Asset, an acronym for Teaching Everyone Assets ...
Tags: toys, toy industry
Clinigen has acquired Cardioxane (dexrazoxane) from Novartis for $33m, which is payable in two tranches. As per the agreement, Clinigen will manufacture, register, distribute, and commercialize the product in countries where current ...
Tags: Clinigen, Cardioxane, Medicine
Venezuelan President Hugo Chavez died Tuesday in Caracas after an almost two-year battle with cancer and 14 years of a dominating socialist presidency that leaves the country with the world's largest oil reserves mired in uncertainty. The ...